Abstract
A well-known metabolite that is released under stress conditions, lactate can be easily assessed as a diagnostic tool for patients under critical illness. The effect of elevated lactate level has been well studied but due to the lack of a standard cut-off value of this metabolite it has not been decided to be used as a biomarker for further care and hemodynamic management of patients suffering from Acute myocardial infarction or any other cardiogenic shock/stress condition. The mechanism(s) associated with disturbed lactate levels under hypothemic conditions ranges from various side effects of reduced temperatures to the hemodynamic effects of hypothermia (i.e., reduced need of vasopressor agents). The present article is focused on the estimation of plasma lactate level in AMI patients along with their cardiac Troponin-I levels to study the correlation between the two and to look into the possibility of dual marker approach to deal wit h complications associated with acute myocardial infarction. Serial measurement of serum lactate with proper time management is recommended for clinically reliability in acute cardiac patients. Keywords: Acute myocardial infarction, Serum lactate, Cardiac TroponinI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Clinical Biochemistry and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
